KP
VRTX icon

Keel Point’s Vertex Pharmaceuticals VRTX Stock Holding History

Keel Point’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$423K Sell
947
-269
-22% -$125K 0.03% 292
2025
Q4 		$551K Buy
1,216
+85
+8% +$36.6K 0.03% 276
2025
Q3 		$443K Sell
1,131
-157
-12% -$65.6K 0.03% 325
2025
Q2 		$573K Buy
1,288
+104
+9% +$47.9K 0.04% 269
2025
Q1 		$574K Buy
1,184
+217
+22% +$101K 0.04% 221
2024
Q4 		$389K Sell
967
-442
-31% -$205K 0.03% 279
2024
Q3 		$655K Sell
1,409
-10
-0.7% -$4.8K 0.05% 191
2024
Q2 		$664K Buy
1,419
+397
+39% +$172K 0.06% 186
2024
Q1 		$427K Buy
1,022
+458
+81% +$194K 0.04% 228
2023
Q4 		$229K Buy
+564
New +$208K 0.03% 305

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return